| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
in00000081854 |
| 005 |
20151008054156.0 |
| 008 |
811105s1981 ja a b 00000 eng d |
| 020 |
|
|
|a 4762202606
|
| 020 |
|
|
|a 0080279937
|
| 035 |
|
|
|a (OCoLC)07909888
|
| 035 |
|
|
|9 AAH9872AM
|
| 040 |
|
|
|a CUX
|c CUX
|d TXA
|d UtOrBLW
|
| 049 |
|
|
|a TXAM
|c [387451]
|
| 090 |
|
|
|a RC271.B45
|b S56 1981
|
| 096 |
|
|
|a QW800 S56 1981
|
| 245 |
0 |
0 |
|a Small molecular immunomodifiers of microbial origin :
|b fundamental and clinical studies of bestatin /
|c edited by Hamao Umezawa.
|
| 250 |
|
|
|a 1st ed.
|
| 263 |
|
|
|a 8012
|
| 264 |
|
1 |
|a Tokyo :
|b Japan Scientific Societies Press ;
|a New York :
|b Pergamon Press,
|c 1981.
|
| 300 |
|
|
|a xiii, 254 pages :
|b illustrations ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographies.
|
| 650 |
|
0 |
|a Bestatin
|x Testing.
|
| 650 |
|
0 |
|a Cancer
|x Chemotherapy.
|
| 650 |
|
0 |
|a Cancer
|x Immunological aspects.
|
| 650 |
|
0 |
|a Bestatin
|x Physiological effect.
|
| 650 |
|
2 |
|a Neoplasms
|x drug therapy.
|
| 650 |
|
2 |
|a Infection
|x drug therapy.
|
| 650 |
|
2 |
|a Adjuvants, Immunologic
|x therapeautic use.
|
| 700 |
1 |
|
|a Umezawa, Hamao,
|d 1914-
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 62e316ba-2a61-3b8a-97c7-03ed84d7aa6d
|i cec9496c-5cdd-36bb-933a-ced5bbfd48ba
|t 0
|
| 952 |
f |
f |
|p ric
|a Texas A&M University
|b Rellis Campus
|c Joint Library Facility
|d Remote Storage
|t 0
|e RC271.B45 S56 1981
|h Library of Congress classification
|i unmediated -- volume
|m A14806229227
|
| 998 |
f |
f |
|a RC271.B45 S56 1981
|t 0
|l Remote Storage
|